Advances in Functional Organic-based Nanosystems for RNA Delivery, Targeting Different Organs DOI Creative Commons

Mahzad Motalleb,

Samira Malyen,

Geyou Ao

и другие.

Materials chemistry horizons., Год журнала: 2024, Номер 3(2), С. 1 - 14

Опубликована: Ноя. 1, 2024

Язык: Английский

Neurotoxicity of Combined Exposure to the Heavy Metals (Pb and As) in Zebrafish (Danio rerio) DOI Creative Commons
Ming Liu, Ping Deng, Guangyu Li

и другие.

Toxics, Год журнала: 2024, Номер 12(4), С. 282 - 282

Опубликована: Апрель 11, 2024

Lead (Pb) and arsenic (As) are commonly occurring heavy metals in the environment produce detrimental impacts on central nervous system. Although they have both been indicated to exhibit neurotoxic properties, it is not known if joint effects, their mechanisms of action likewise unknown. In this study, zebrafish were exposed different concentrations Pb (40 μg/L, 4 mg/L), As (32 3.2 mg/L) combinations μg/L + 32 mg/L for 30 days. The histopathological analyses showed significant brain damage characterized by glial scar formation ventricular enlargement all groups. addition, either or staining inhibited swimming speed zebrafish, which was enhanced high a mixture. To elucidate underlying mechanisms, we examined changes acetylcholinesterase (AChE) activity, neurotransmitter (dopamine, 5-hydroxytryptamine) levels, HPI axis-related hormone (cortisol epinephrine) contents neurodevelopment-related gene expression brain. observations suggest that combined exposure can cause abnormalities behavior ultimately exacerbate neurotoxicity interfering with cholinergic system, dopamine 5-hydroxytryptamine signaling, axis function as well neuronal development. This study provides an important theoretical basis mixed toxicity aquatic organisms.

Язык: Английский

Процитировано

9

The neuroimmune nexus: unraveling the role of the mtDNA-cGAS-STING signal pathway in Alzheimer’s disease DOI Creative Commons

Shuiyue Quan,

Xiaofeng Fu,

Huimin Cai

и другие.

Molecular Neurodegeneration, Год журнала: 2025, Номер 20(1)

Опубликована: Март 4, 2025

The relationship between Alzheimer's disease (AD) and neuroimmunity has gradually begun to be unveiled. Emerging evidence indicates that cyclic GMP-AMP synthase (cGAS) acts as a cytosolic DNA sensor, recognizing damage-associated molecular patterns (DAMPs), inducing the innate immune response by activating stimulator of interferon genes (STING). Dysregulation this pathway culminates in AD-related neuroinflammation neurodegeneration. A substantial body mitochondria are involved critical pathogenic mechanisms AD, whose damage leads release mitochondrial (mtDNA) into extramitochondrial space. This leaked mtDNA serves DAMP, various pattern recognition receptors defense networks brain, including cGAS-STING pathway, ultimately leading an imbalance homeostasis. Therefore, modulation mtDNA-cGAS-STING restore neuroimmune homeostasis may offer promising prospects for improving AD treatment outcomes. In review, we focus on during stress activation pathway. Additionally, delve research progress further discuss primary directions potential hurdles developing targeted therapeutic drugs, gain deeper understanding pathogenesis provide new approaches its therapy.

Язык: Английский

Процитировано

1

An Overview on the Physiopathology of the Blood–Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery DOI Creative Commons
Francesca Susa, Silvia Arpicco, Candido Fabrizio Pirri

и другие.

Pharmaceutics, Год журнала: 2024, Номер 16(7), С. 849 - 849

Опубликована: Июнь 22, 2024

The state of well-being and health our body is regulated by the fine osmotic biochemical balance established between cells different tissues, organs, systems. Specific districts human are defined, kept in correct functioning, and, therefore, protected from exogenous or endogenous insults both mechanical, physical, biological nature presence barrier In addition to placental barrier, which even acts as a linker two organisms, mother fetus, all barriers, including blood-brain (BBB), blood-retinal blood-nerve blood-lymph blood-cerebrospinal fluid operate maintain physiological homeostasis within tissues organs. From pharmaceutical point view, most challenging undoubtedly BBB, since its notably complicates treatment brain disorders. BBB action can impair delivery chemical drugs biopharmaceuticals into brain, reducing their therapeutic efficacy and/or increasing unwanted bioaccumulation surrounding healthy tissues. Recent nanotechnological innovation provides advanced biomaterials ad hoc customized engineering functionalization methods able assist brain-targeted drug delivery. this context, lipid nanocarriers, synthetic (liposomes, solid nanoparticles, nanoemulsions, nanostructured carriers, niosomes, proniosomes, cubosomes) cell-derived ones (extracellular vesicles cell membrane-derived nanocarriers), considered one successful systems due reasonable biocompatibility ability cross BBB. This review aims provide complete up-to-date view on varied whether FDA-approved, involved clinical trials, used vitro vivo studies, for inflammatory, cancerous, infectious diseases.

Язык: Английский

Процитировано

6

Suppressing UBE2N ameliorates Alzheimer's disease pathology through the clearance of amyloid beta DOI Creative Commons
Chen Zhang,

Qingqing Jia,

Longhong Zhu

и другие.

Alzheimer s & Dementia, Год журнала: 2024, Номер 20(9), С. 6287 - 6304

Опубликована: Июль 17, 2024

Abstract INTRODUCTION Aging is one of the risk factors for early onset Alzheimer's disease (AD). We previously discovered that age‐dependent increase in Ubiquitin Conjugating Enzyme E2 N (UBE2N) plays a role accumulation misfolded proteins through K63 ubiquitination, which has been linked to AD pathogenesis. However, impact UBE2N on amyloid pathology and clearance remained unknown. RESULTS observed elevated during beta (Aβ) generation brains 5×FAD, APP/PS1 mice, patients with AD, comparison healthy individuals. overexpression exacerbated deposition 5×FAD mice senescent monkeys, whereas knocking down via CRISPR/Cas9 reduced Aβ cognitive deficiency. Moreover, pharmacological inhibition ameliorated subsequent transcript defects mice. DISCUSSION have expression critical regulator pathology. Our findings suggest could serve as potential target advancement therapeutics. Highlights level was mouse patients' brains. monkey. Drug

Язык: Английский

Процитировано

6

Recent advance on extracellular vesicle labeling: From strategy to probe DOI
Sijung Hu,

Xinwen Chang,

Qiaojiao Ding

и другие.

Coordination Chemistry Reviews, Год журнала: 2025, Номер 534, С. 216601 - 216601

Опубликована: Март 10, 2025

Язык: Английский

Процитировано

0

Extracellular vesicles DOI

Mariana Ottaiano Gonçalves,

Juliana Fortes Di Iorio,

Gabriela Villa Marin

и другие.

Current topics in membranes, Год журнала: 2024, Номер unknown, С. 1 - 31

Опубликована: Янв. 1, 2024

Язык: Английский

Процитировано

1

Research Progress of Neurogenic Exosomes in the Treatment of Alzheimer’s Disease DOI

思柔 黄

Advances in Clinical Medicine, Год журнала: 2024, Номер 14(09), С. 1034 - 1041

Опубликована: Янв. 1, 2024

Язык: Английский

Процитировано

0

Advances in Functional Organic-based Nanosystems for RNA Delivery, Targeting Different Organs DOI Creative Commons

Mahzad Motalleb,

Samira Malyen,

Geyou Ao

и другие.

Materials chemistry horizons., Год журнала: 2024, Номер 3(2), С. 1 - 14

Опубликована: Ноя. 1, 2024

Язык: Английский

Процитировано

0